Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Rotate sites with each weekly injection repeating the same spot leads to lumps and uneven absorption
Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk, the Danish pharmaceutical company also responsible for semaglutide (Ozempic, Wegovy)
Skinny shots typically contain a blend of vitamins, amino acids, and sometimes prescription medications that may help the body metabolize fat more efficiently
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
